These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18036075)

  • 1. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Transfusion; 2007 Dec; 47(12):2338-47. PubMed ID: 18036075
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Vox Sang; 2007 Aug; 93(2):179-82. PubMed ID: 17683364
    [No Abstract]   [Full Text] [Related]  

  • 3. The consensus development process in transfusion medicine: does it add value?
    Sher GD; Devine DV
    Transfusion; 2007 Dec; 47(12):2176-9. PubMed ID: 18036072
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk-based decision-making for blood safety: preliminary report of a consensus conference.
    Stein J; Besley J; Brook C; Hamill M; Klein E; Krewski D; Murphy G; Richardson M; Sirna J; Skinner M; Steiner R; van Aken P; Devine D
    Vox Sang; 2011 Nov; 101(4):277-81. PubMed ID: 21781125
    [No Abstract]   [Full Text] [Related]  

  • 5. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 6. Health technology assessment in Scotland.
    Kohli HS
    Natl Med J India; 2003; 16(5):275-6. PubMed ID: 14680286
    [No Abstract]   [Full Text] [Related]  

  • 7. [When new methods are about to be introduced].
    Graff BA; Thürmer H; Søreide O; Norderhaug IN
    Tidsskr Nor Laegeforen; 2008 Feb; 128(4):472. PubMed ID: 18274585
    [No Abstract]   [Full Text] [Related]  

  • 8. International Association for Biologicals Symposium: "Advances in Transfusion Safety", Cambridge, UK. Foreword.
    Allain JP
    Biologicals; 2010 Jan; 38(1):1. PubMed ID: 20042348
    [No Abstract]   [Full Text] [Related]  

  • 9. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the quality of mini-HTA.
    Kidholm K; Ehlers L; Korsbek L; Kjaerby R; Beck M
    Int J Technol Assess Health Care; 2009 Jan; 25(1):42-8. PubMed ID: 19126250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion medicine and proteomics. Alliance or coexistence?
    Thiele T; Steil L; Völker U; Greinacher A
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s16-25. PubMed ID: 20606745
    [No Abstract]   [Full Text] [Related]  

  • 12. Research of admission management standards and working patterns of first class medical technologies.
    Wu S; Ge Y; Xu X; Xuan Y; Chen T
    Chin Med J (Engl); 2014; 127(15):2860-2. PubMed ID: 25146627
    [No Abstract]   [Full Text] [Related]  

  • 13. New technologies.
    Miesenböck G; Morris RG
    Curr Opin Neurobiol; 2005 Oct; 15(5):557-9. PubMed ID: 16143508
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk assessment and cost-effectiveness/utility analysis.
    Busch M; Walderhaug M; Custer B; Allain JP; Reddy R; McDonough B
    Biologicals; 2009 Apr; 37(2):78-87. PubMed ID: 19243972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies in atrial fibrillation ablation.
    Burkhardt JD; Natale A
    Circulation; 2009 Oct; 120(15):1533-41. PubMed ID: 19822816
    [No Abstract]   [Full Text] [Related]  

  • 16. [Consensus and non-consensus on portions of the blood transfusion policy].
    van Aken WG
    Ned Tijdschr Geneeskd; 1983 Oct; 127(40):1818-21. PubMed ID: 6633731
    [No Abstract]   [Full Text] [Related]  

  • 17. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmonization of evidence requirements for health technology assessment in reimbursement decision making.
    Hutton J; Trueman P; Facey K
    Int J Technol Assess Health Care; 2008; 24(4):511-7. PubMed ID: 18828948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 7th International Conference on Advanced Technologies and Treatments for Diabetes.
    J Diabetes; 2014 Jul; 6(4):274-5. PubMed ID: 24618124
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical technologies can carry big payoff, big costs. How to assess needs and build strategies.
    Carpenter D
    Trustee; 2008; 61(7):8-12, 14, 19 passim. PubMed ID: 18773556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.